400 related articles for article (PubMed ID: 26838726)
1. Reduction of Streptococcus pneumoniae Colonization and Dissemination by a Nonopsonic Capsular Polysaccharide Antibody.
Doyle CR; Pirofski LA
mBio; 2016 Feb; 7(1):e02260-15. PubMed ID: 26838726
[TBL] [Abstract][Full Text] [Related]
2. A Capsular Polysaccharide-Specific Antibody Alters Streptococcus pneumoniae Gene Expression during Nasopharyngeal Colonization of Mice.
Doyle CR; Moon JY; Daily JP; Wang T; Pirofski LA
Infect Immun; 2018 Jul; 86(7):. PubMed ID: 29735523
[TBL] [Abstract][Full Text] [Related]
3. Isolation and Characterization of Human Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide 3.
Babb R; Doyle CR; Pirofski LA
Microbiol Spectr; 2021 Dec; 9(3):e0144621. PubMed ID: 34756090
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to Streptococcus pneumoniae capsular polysaccharide enhance pneumococcal quorum sensing.
Yano M; Gohil S; Coleman JR; Manix C; Pirofski LA
mBio; 2011; 2(5):. PubMed ID: 21917597
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of pneumococcal capsular polysaccharide-specific antibodies to serotype 3 Streptococcus pneumoniae requires macrophages.
Fabrizio K; Manix C; Tian H; van Rooijen N; Pirofski LA
Vaccine; 2010 Nov; 28(47):7542-50. PubMed ID: 20800700
[TBL] [Abstract][Full Text] [Related]
6. Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivo.
Fabrizio K; Manix C; Guimaraes AJ; Nosanchuk JD; Pirofski LA
Clin Vaccine Immunol; 2010 May; 17(5):713-21. PubMed ID: 20200186
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice.
Tian H; Weber S; Thorkildson P; Kozel TR; Pirofski LA
Infect Immun; 2009 Apr; 77(4):1502-13. PubMed ID: 19168739
[TBL] [Abstract][Full Text] [Related]
8. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease.
Emmadi M; Khan N; Lykke L; Reppe K; G Parameswarappa S; Lisboa MP; Wienhold SM; Witzenrath M; Pereira CL; Seeberger PH
J Am Chem Soc; 2017 Oct; 139(41):14783-14791. PubMed ID: 28945368
[TBL] [Abstract][Full Text] [Related]
9. Serum opsonic activity in infants with sickle-cell disease immunized with pneumococcal polysaccharide protein conjugate vaccine. The Pneumococcal Conjugate Vaccine Study Group.
Nowak-Wegrzyn A; Winkelstein JA; Swift AJ; Lederman HM
Clin Diagn Lab Immunol; 2000 Sep; 7(5):788-93. PubMed ID: 10973456
[TBL] [Abstract][Full Text] [Related]
10. Capsular Polysaccharide (CPS) Release by Serotype 3 Pneumococcal Strains Reduces the Protective Effect of Anti-Type 3 CPS Antibodies.
Choi EH; Zhang F; Lu YJ; Malley R
Clin Vaccine Immunol; 2016 Feb; 23(2):162-7. PubMed ID: 26677201
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and protective efficacy of monovalent PCVs containing 22F and 33F polysaccharides in mouse models of colonization and co-infection.
Khan MN; Pryharski K; Pichichero ME
Vaccine; 2018 Sep; 36(38):5701-5708. PubMed ID: 30107993
[TBL] [Abstract][Full Text] [Related]
12. IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine.
Campos IB; Herd M; Moffitt KL; Lu YJ; Darrieux M; Malley R; Leite LC; Gonçalves VM
Vaccine; 2017 Mar; 35(9):1306-1315. PubMed ID: 28161422
[TBL] [Abstract][Full Text] [Related]
13. Characterization of gene use and efficacy of mouse monoclonal antibodies to Streptococcus pneumoniae serotype 8.
Yano M; Pirofski LA
Clin Vaccine Immunol; 2011 Jan; 18(1):59-66. PubMed ID: 21068211
[TBL] [Abstract][Full Text] [Related]
14. Pneumococcal Capsular Polysaccharide Immunity in the Elderly.
Adler H; Ferreira DM; Gordon SB; Rylance J
Clin Vaccine Immunol; 2017 Jun; 24(6):. PubMed ID: 28424198
[TBL] [Abstract][Full Text] [Related]
15. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial.
Dagan R; Patterson S; Juergens C; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA
Clin Infect Dis; 2013 Oct; 57(7):952-62. PubMed ID: 23804191
[TBL] [Abstract][Full Text] [Related]
16. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP
Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
[TBL] [Abstract][Full Text] [Related]
17. A serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibody requires Fcγ receptor III and macrophages to mediate protection against pneumococcal pneumonia in mice.
Weber S; Tian H; van Rooijen N; Pirofski LA
Infect Immun; 2012 Apr; 80(4):1314-22. PubMed ID: 22290146
[TBL] [Abstract][Full Text] [Related]
18. Protection against Streptococcus pneumoniae Invasive Pathogenesis by a Protein-Based Vaccine Is Achieved by Suppression of Nasopharyngeal Bacterial Density during Influenza A Virus Coinfection.
Khan MN; Xu Q; Pichichero ME
Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895132
[TBL] [Abstract][Full Text] [Related]
19. Correlation of higher antibody levels to pneumococcal proteins with protection from pneumococcal acute otitis media but not protection from nasopharyngeal colonization in young children.
Xu Q; Casey JR; Almudevar A; Pichichero ME
Clin Microbiol Infect; 2017 Jul; 23(7):487.e1-487.e6. PubMed ID: 28143785
[TBL] [Abstract][Full Text] [Related]
20. Imputing the Direct and Indirect Effectiveness of Childhood Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease by Surveying Temporal Changes in Nasopharyngeal Pneumococcal Colonization.
Nzenze SA; Madhi SA; Shiri T; Klugman KP; de Gouveia L; Moore DP; Karstaedt AS; Tempia S; Nunes MC; von Gottberg A
Am J Epidemiol; 2017 Aug; 186(4):435-444. PubMed ID: 28482004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
